Scholars@Duke
Journal cover image

Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion.

Publication ,  Other
Hamilton, E; Blackwell, K; Hobeika, AC; Clay, TM; Broadwater, G; Ren, XR; Chen, W; Castro, H; Lehmann, F; Spector, N; Wei, J; Osada, T ...
Published in: J Transl Med
2013
Published version (DOI) Link to item

Duke Scholars

Kimberly Lynn Blackwell
Author Kimberly Lynn Blackwell Medicine, Medical Oncology
Amy Claudine Hobeika
Author Amy Claudine Hobeika Surgery, Surgical Sciences
Takuya Osada
Author Takuya Osada Surgery, Surgical Sciences
Herbert Kim Lyerly
Author Herbert Kim Lyerly Surgery, Surgical Sciences
Michael Aaron Morse
Author Michael Aaron Morse Medicine, Medical Oncology

Published In

J Transl Med

DOI

10.1186/1479-5876-11-82

EISSN

1479-5876

Publication Date

2013

Volume

11

Start / End Page

82

Location

England

Related Subject Headings

  • Immunology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hamilton, E., Blackwell, K., Hobeika, A. C., Clay, T. M., Broadwater, G., Ren, X. R., … Morse, M. A. (2013). Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion. J Transl Med. England. https://doi.org/10.1186/1479-5876-11-82
Hamilton, E., K. Blackwell, A. C. Hobeika, T. M. Clay, G. Broadwater, X. R. Ren, W. Chen, et al. “Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion.” J Transl Med, 2013. https://doi.org/10.1186/1479-5876-11-82.
Hamilton E, Blackwell K, Hobeika AC, Clay TM, Broadwater G, Ren XR, et al. Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion. Vol. 11, J Transl Med. 2013. p. 82.
Hamilton, E., et al. “Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion.” J Transl Med, vol. 11, 2013, p. 82. Pubmed, doi:10.1186/1479-5876-11-82.
Hamilton E, Blackwell K, Hobeika AC, Clay TM, Broadwater G, Ren XR, Chen W, Castro H, Lehmann F, Spector N, Wei J, Osada T, Lyerly HK, Morse MA. Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion. J Transl Med. 2013. p. 82.
Journal cover image

Published In

J Transl Med

DOI

10.1186/1479-5876-11-82

EISSN

1479-5876

Publication Date

2013

Volume

11

Start / End Page

82

Location

England

Related Subject Headings

  • Immunology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences